StockTipsArenaBeta

BUY TruAlt Bioenergy Limited — Ansh Jogendra Bhilwar

BUYTruAlt Bioenergy Limited
TruAlt Bioenergy share price target & all analyst calls

byAnsh Jogendra BhilwarHorizon: NA (inferred Swing (≤2wk))26 Oct 2026via Zee Business (Live)

Entry₹403.3Inferred
Target₹425
Total upside +5.38% (call closed)
Stop loss₹397-1.56% risk
Exit₹397Stop-loss hit — time not yet verified
Stop-loss hit-1.56%
Follow Ansh Jogendra Bhilwar for new calls(25% target hit, 72 closed calls)Get alertsWatch TRUALT for new buy/sell callsGet alertsSee 61 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 2:40 pm IST
1 supporting2 neutral1 opposing
Supports the BUY call (1)

The company reported strong H1 FY27 growth with revenue rising 243% to 1,437.98 crore, EBITDA up 532% to 233.92 crore, and PAT of 94.27 crore.

NSE · Press Release·23 Oct · 2d ago

(opens in new tab)
Neutral / worth noting (2)

Outcome of Board Meeting for approval of Unaudited Financial Results(Standalone and Consolidated) along with Limited Review Report thereon, for the Quarter and Half Year ended on September 30, 2026.

BSE · Board Meeting·23 Oct · 2d ago

(opens in new tab)

TruAlt Bioenergy Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·23 Oct · 2d ago

(opens in new tab)
Weighs against the BUY call (1)

MACD below its signal line — bearish momentum

Technicals · macd·26 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

More from Ansh Jogendra Bhilwar

Every call and its outcome